ICD-10 Coding for Adenocarcinoma of the Lung(C34.0, C34.11, C34.11B)
Explore detailed ICD-10 coding guidelines for adenocarcinoma of the lung, including specific codes, documentation requirements, and common pitfalls.
Complete code families applicable to Adenocarcinoma of the Lung
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C34.11 | Malignant neoplasm of upper lobe, right bronchus or lung | Use when adenocarcinoma is confirmed in the upper lobe of the right lung. |
|
| C34.12 | Malignant neoplasm of upper lobe, left bronchus or lung | Use when adenocarcinoma is confirmed in the upper lobe of the left lung. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutAdenocarcinoma of the Lung
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Adenocarcinoma of the Lung.
Failing to document tobacco use history.
Impact
Clinical: May affect treatment decisions., Regulatory: Non-compliance with documentation standards., Financial: Potential loss of reimbursement for related care.
Mitigation
Include tobacco use history in initial patient assessment., Regularly update patient records with lifestyle factors.
Using unspecified codes like C34.90 when specific location is known.
Impact
Reimbursement: May lead to lower reimbursement rates., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases accuracy of clinical data.
Mitigation
Ensure documentation specifies the lobe and laterality to use specific codes like C34.11 or C34.12.
Use of unspecified codes
Impact
High risk of audit if unspecified codes are used when specific information is available.
Mitigation
Always document specific tumor location and laterality.